Some TILs behave as effector cells, such as CD8+ and natural killer lymphocytes,4 inducing a cytotoxic cascade resulting in tumor cell death, while other TILs show a regulatory role inhibiting the anti‐tumor activity of effector T cells, mainly CD4+ lymphocytes.5 This evidence concerns the gene CD8A and neoplasm.